Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User (Hospitals & Sleep Laboratories and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3324
- Pages: 180
-
Format:
Sleep Apnea Diagnostics Market Overview:
The global sleep apnea diagnostics market was valued at $99million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025.
Sleep apnea is a sleep disorder that fluctuates with the patients breathing pattern. It may decrease or even stop patients breathing completely during sleep. In few cases, it may pause the breathing (called apnea), which can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated.
The major key factors that drive the growth of the sleep apnea diagnostics market include rise in sedentary lifestyle diseases such as diabetes & others and surge in geriatric population. Obesity is considered one of the major risk factor for the development and progression of sleep apnea. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, high cost associated with these devices, limited reimbursement of these devices, and low patient awareness regarding sleep apnea are projected to hinder the market growth. Moreover, increase in preference for home healthcare devices among patients is projected to create lucrative growth opportunities in the near future.
The global sleep apnea diagnostics market is segmented based on product and region. Based on product, the market is divided into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end user, the market is bifurcated into hospitals & sleep laboratories and home care settings. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Sleep Apnea Diagnostics Market:
The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Sleep Apnea Diagnostics Key Market Segments:
By Product
Polysomnography Device (PSG)
Clinical PSG Device
Ambulatory PSG Device
Sleep Apnea Screening Device
Actigraphy Monitoring Device
Respiratory Polygraph
Oximeter
Finger Tip Oximeter
Handheld Oximeter
Wrist-worn Oximeter
Tabletop Oximeter
Others
By End User
Hospitals & Sleep Laboratories
Home Care Settings
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
KEY MARKET PLAYERS
Cadwell Laboratories Inc.
DeVilbiss Healthcare LLC.
Koninklijke Philips N.V
Medtronic plc
Mindray
Natus Medical Incorporated
Nihon Kohden Corporation
Resmed
Smiths Medical
SomnoMedics
The other players in the value chain include (profiles not included in the report):
Cleveland Medical Devices, Inc.
Compumedics Ltd.
Fisher & Paykel Healthcare Limited
Vyaire Medical, Inc
Becton, Dickinson and Company
BMC Medical Co., Ltd
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of obesity across the globe
3.4.1.2. Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3. Technological advancements in sleep apnea diagnostic devices
3.4.2. Restraints
3.4.2.1. High cost associated with the sleep apnea diagnostic devices
3.4.2.2. Lack of awareness among patients regarding sleep apnea
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing economies
CHAPTER 4: SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Polysomnography device (PSG)
4.2.1. Key trends and opportunities
4.2.2. List of Distributors
4.2.3. Market size and forecast
4.2.4. Market analysis, by country
4.2.4.1. Clinical PSG Device
4.2.4.2. Market size and forecast
4.2.4.3. Ambulators PSG Device
4.2.4.4. Market size and forecast
4.3. Sleep apnea screening device
4.3.1. Key trends and opportunities
4.3.2. List of ditributors
4.3.3. Market size and forecast
4.3.4. Market analysis, by country
4.4. Actigraphy monitoring device
4.4.1. Key trends and opportunities
4.4.2. List of distributors
4.4.3. Market size and forecast
4.4.4. Market analysis, by country
4.5. Respiratory polygraph
4.5.1. Key trends and opportunities
4.5.2. List of distributors
4.5.3. Market size and forecast
4.5.4. Market analysis, by country
4.6. Oximeter
4.6.1. Key trends and opportunities
4.6.2. List of distributors
4.6.3. Market size and forecast
4.6.4. Market analysis, by country
4.6.5. Finger Tip Oximeter
4.6.5.1. Market size and forecast
4.6.6. Handheld Oximeter
4.6.6.1. Market size and forecast
4.6.7. Wrist-worn Oximeter
4.6.7.1. Market size and forecast
4.6.8. Tabletop Oximeter
4.6.8.1. Market size and forecast
CHAPTER 5: SLEEP APNEA DIAGNOSTICS MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals & sleep laboratories
5.2.1. List of distributors
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Home care settings
5.3.1. List of distributors
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
CHAPTER 6: SLEEP APNEA DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. List of distributors
6.2.3. North America market size and forecast, by country
6.2.3.1. U.S. market size and forecast, by product
6.2.3.2. U.S. market size and forecast, by end user
6.2.3.3. Canada market size and forecast, by product
6.2.3.4. Canada market size and forecast, by end user
6.2.3.5. Mexico market size and forecast, by product
6.2.3.6. Mexico market size and forecast, by end user
6.2.4. North America market size and forecast, by product
6.2.5. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. List of distributors
6.3.3. Europe market size and forecast, by country
6.3.3.1. Germany market size and forecast, by product
6.3.3.2. Germany market size and forecast, by end user
6.3.3.3. UK market size and forecast, by product
6.3.3.4. UK market size and forecast, by end user
6.3.3.5. France market size and forecast, by product
6.3.3.6. France market size and forecast, by end user
6.3.3.7. Italy market size and forecast, by product
6.3.3.8. Italy market size and forecast, by end user
6.3.3.9. Spain market size and forecast, by product
6.3.3.10. Spain market size and forecast, by end user
6.3.3.11. Rest of Europe market size and forecast, by Product
6.3.3.12. Rest of Europe market size and forecast, by end user
6.3.4. Europe market size and forecast, by product
6.3.5. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. List of distributors
6.4.3. Asia-Pacific market size and forecast, by country
6.4.3.1. Japan market size and forecast, by product
6.4.3.2. Japan market size and forecast, by end user
6.4.3.3. China market size and forecast, by product
6.4.3.4. China market size and forecast, by end user
6.4.3.5. India market size and forecast, by product
6.4.3.6. India market size and forecast, by end user
6.4.3.7. Australia market size and forecast, by product
6.4.3.8. Australia market size and forecast, by end user
6.4.3.9. Rest of Asia-Pacific market size and forecast, by product
6.4.3.10. Rest of Asia-Pacific market size and forecast, by end user
6.4.4. Asia-Pacific market size and forecast, by product
6.4.5. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. List of distributors
6.5.3. LAMEA market size and forecast, by country
6.5.3.1. Brazil market size and forecast, by product
6.5.3.2. Brazil market size and forecast, by end user
6.5.3.3. South Africa market size and forecast, by product
6.5.3.4. South Africa market size and forecast, by end user
6.5.3.5. Saudi Arabia market size and forecast, by product
6.5.3.6. Saudi Arabia market size and forecast, by end user
6.5.3.7. Rest of LAMEA market size and forecast, by product
6.5.3.8. Rest of LAMEA market size and forecast, by end user
6.5.4. LAMEA market size and forecast, by product
6.5.5. LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. CADWELL INDUSTRIES INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.2. DEVILBISS HEALTHCARE
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key Strategic Moves:
7.4. MEDTRONIC PLC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segment
7.4.4. Product portfolio
7.4.5. Business performance
7.5. MINDRAY MEDICAL INTERNATIONAL LIMITED
7.5.1. Company overview
7.5.2. Operating business segment
7.6. NATUS MEDICAL INCORPORATED
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Operating business segments
7.6.5. Business performance
7.7. NIHON KOHDEN CORPORATION
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. RESMED INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segment
7.8.4. Product portfolio
7.8.5. Business performance
7.9. SMITHS GROUP PLC. (SMITHS MEDICAL)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key Strategic Moves:
7.10. SOMNOMEDICS GmbH
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
